Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Neoplasms × Oncolytic Virotherapy × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Glioblastoma 3 Virus Diseases 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 CRC 1 Breast Neoplasms 1 Astrocytoma 1

Interventions

Gemcitabine 405 Oxaliplatin 130 Fluorouracil 124 130-nm albumin-bound paclitaxel 108 Capecitabine 100 Albumin-Bound Paclitaxel 90 Leucovorin 87 Irinotecan 86 Radiotherapy 76 Taxes 64 Radiosurgery 63 Cisplatin 55 Erlotinib Hydrochloride 44 Drug Therapy 41 folfirinox 40 Magnetic Resonance Spectroscopy 37 pembrolizumab 35 Blood Specimen Collection 32 S 1 (combination) 31 Pancreaticoduodenectomy 31 Docetaxel 31 Nivolumab 30 Bevacizumab 29 Surgical Procedures, Operative 25 Cyclophosphamide 25 Biopsy 25 irinotecan sucrosofate 24 Specimen Handling 22 Radiation 22 Standard of Care 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06196671 2025-08-07

PTCA199-8

Fudan University

Phase 2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡